Oliver Lagore Vanvalin Investment Group’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-748
| Closed | -$3.81K | – | 732 |
|
|
2024
Q1 | $3.81K | Hold |
748
| – | – | ﹤0.01% | 537 |
|
|
2023
Q4 | $6.96K | Sell |
748
-5
| -0.7% | -$47 | ﹤0.01% | 469 |
|
|
2023
Q3 | $4.93K | Hold |
753
| – | – | ﹤0.01% | 545 |
|
|
2023
Q2 | $6.12K | Hold |
753
| – | – | ﹤0.01% | 543 |
|
|
2023
Q1 | $6.45K | Sell |
753
-17
| -2% | -$146 | ﹤0.01% | 448 |
|
|
2022
Q4 | $7.13K | Buy |
+770
| New | +$7.13K | ﹤0.01% | 413 |
|